Surgery for atrial fibrillation in patients with mitral valve disease: Results at five years from the International Registry of Atrial Fibrillation Surgery

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Mitral stenosis with pulmonary hypertension: We should operate early

Endoscopic Robotic Mitral Valve Surgery

“Lead from the front”: Participative leadership

Amine Mazine, MD, MSc, Subodh Verma, MD, PhD, Bobby Yanagawa, MD, PhD

Murray H. Kwon, MD The Journal of Thoracic and Cardiovascular Surgery

Pulmonary hypertension in valve disease: A beast of the past?

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

James R. Edgerton, MD, Cecile Mahoney, BS, Michael J

Form ever follows function

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

The Journal of Thoracic and Cardiovascular Surgery

A new approach: Ischemic mitral regurgitation guidelines by and for surgeons Patrick M. McCarthy, MD The Journal of Thoracic and Cardiovascular Surgery

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery Vincent Chan, MD, MPH, Thierry.

How should we treat air leaks?

Go on-pump or off-pump in diabetic patients?

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Conduit conundrum: If not two, why three?

Sinus node structural changes in patients with long-standing chronic atrial fibrillation Aquilino Hurlé, MD, PhD, Vicente Climent, MD, PhD, Damian Sánchez-Quintana,

The variability of the mitral valve anatomy and terminology

Quality of mitral valve surgery at the United States Department of Veterans Affairs Juan A. Crestanello, MD The Journal of Thoracic and Cardiovascular.

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

It's not “just a shunt” but sometimes it should be…

A first start for lung transplantation?

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Left sinus of Valsalva aneurysm: Rare disease, rarer presentation

Left atrial pressure measurement in a rat is currently impossible due to size limitations of balloon occlusion catheter Filip Konecny, MSc, DVM, PhD

Replicating the success of mitral valve repair in the aortic valve

Attachment disorder in thoracoabdominal surgery

The Ross procedure: Time to reevaluate the guidelines

Manuel J. Antunes, MD, PhD, DSc

Thirty-year experience with a bileaflet mechanical valve prosthesis

Commentary: Ongoing advancements in the understanding of tricuspid valve dynamics and functional geometry Daniel J.P. Burns, MD, MPhil The Journal of.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Warfarin or aspirin after mitral valve repair: Why work harder?

The harder one looks, the more one finds

Innovation in cardiothoracic surgical training

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

The continuing challenge of congenital heart disease in China

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Commentary: Have mitral valve simulators made it to reality?

“The more things change…”: The challenges ahead

Commentary: Judgment day: Should you add atrial fibrillation ablation?

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Managing conflicts of interest

More than vital: Who bears the burden?

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Preoperative PFTs: The answer is blowing in the wind

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Did you like Terminator 3 better than Terminator 2

How do we follow up our patients

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Marc Gillinov, MD, Per Wierup, MD, PhD, Stephanie Mick, MD

Zipping up after a median sternotomy: Are we at the end of the wire?

Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm? Andrew W. ElBardissi, MD, MPH, Daniel.

Presentation transcript:

Surgery for atrial fibrillation in patients with mitral valve disease: Results at five years from the International Registry of Atrial Fibrillation Surgery Joao Melo, MD, PhD, Teresa Santiago, MSc, Carlos Aguiar, MD, Eva Berglin, MD, PhD, Michael Knaut, MD, Ottavio Alfieri, MD, PhD, Stefano Benussi, MD, PhD, Haw Sie, MD, Mathew Williams, MD, Fernando Hornero, MD, PhD, Giuseppi Marinelli, MD, Paul Ridley, MD, Enrique Fulquet-Carreras, MD, António Ferreira, MD The Journal of Thoracic and Cardiovascular Surgery Volume 135, Issue 4, Pages 863-869 (April 2008) DOI: 10.1016/j.jtcvs.2007.08.069 Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Actuarial survival after the first year of follow-up for stable sinus rhythm (sSR) versus other rhythms. The Journal of Thoracic and Cardiovascular Surgery 2008 135, 863-869DOI: (10.1016/j.jtcvs.2007.08.069) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Actuarial survival after the first year of follow-up according to stable sinus rhythm (sSR) versus stable atrial fibrillation (sAF) versus “other.” The Journal of Thoracic and Cardiovascular Surgery 2008 135, 863-869DOI: (10.1016/j.jtcvs.2007.08.069) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Survival free of thromboembolic events according to rhythm. sSR, Stable sinus rhythm. The Journal of Thoracic and Cardiovascular Surgery 2008 135, 863-869DOI: (10.1016/j.jtcvs.2007.08.069) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions